All News

Why is this patient listing ciprofloxacin as an allergy?

If this new indication is approved, Invokana® would be the first diabetes medication to treat both T2D and CKD.

Kratom is a plant native to Southeast Asia which can produce stimulant and opioid-like effects.

Official with the FDA today granted accelerated approval to erdafitinib (Balversa, Janssen) for adult patients with locally advanced or metastatic bladder cancer.

Bladder cancers are associated with genetic mutations that are present in the patient's bladder or entire the lining of the lower urinary tract.

A study, which tested naturally occurring homoisoflavonoids found in the Hyacinthaceae plant family and their synthetic derivatives, focused on the abnormal growth of new blood vessel cells in the eye that are linked to types of blindness.

The expanded first-line indication makes pembrolizumab (Keytruda) monotherapy an option for more patients with non-small cell lung cancer.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The expansion of the Valyou Savings Program helps to address the challenge many patients face regarding unpredictable and unaffordable pricing for their insulin, according to the company.

The action requires the company to revise safety information that women and their health care professionals need when considering use of the drug.

There are currently firms working to use artificial intelligence in hopes that it could contribute to minimizing the impact of the opioid epidemic.

The supplement (Equelle, Pharmavite) relies on S-equol, an intestinal bacterial metabolite of the soybean isoflavone daidzein that binds to select estrogen receptors in the body.

Across the United States, 5090 individuals were matched to approximately 2500 pharmacy residency programs.

Cytomegalovirus may contribute to faster cystic fibrosis progression, but further studies are warranted to confirm these findings.

Top news of the day from across the health care landscape.

The 4-drug combination tablet (Symtuza) was approved by the FDA in July 2018 for infection of HIV type 1 (HIV-1) in treatment-naïve and certain virologically suppressed adults.

The digital solution is designed to help build foundational knowledge and skills, while assessing users' areas of strength and areas of needed focus.

The APPA industry awards each year recognize outstanding performances in the pharmactical industry, lauding both companies and individuals for their innovation, dedication and best-in-class service.

The AMCP Managed Care & Specialty Pharmacy Annual Meeting featured various discussions on strategies to manage complex patients and achieve optimal outcomes, highlighted by an exciting string of innovations and policy shifts.

Top news of the day from across the health care landscape.

What is an antioxidant, and how do they affect our health?

As specialty pharmacies continue to grow, health systems will need to evaluate whether an integrated specialty pharmacy is right for them.

Romosozumab-aqqg (Evenity, Amgen) works to decrease the risk of fracture by increasing new bone formation in women with postmenopausal osteoporosis.

Romosozumab-aqqg (Evenity, Amgen) works to decrease the risk of fracture by increasing new bone formation in women with postmenopausal osteoporosis.

On Tuesday, a US Senate Finance Committee hearing on drug pricing focused on addressing the role of pharmacy benefit managers (PBMs) in determining cost to patients.

The hearing, “Drug Pricing in America: A Prescription for Change, Part III,” gave PBMs a chance to testify about the issue and provide insight into what the role entails.

Plague is a serious medical condition recognized by public health authorities globally as a potential agent of bioterrorism.